IL‐22‐mediated renal metabolic reprogramming via PFKFB3 to treat kidney injury

Wei Chen(Eon Corporation (United States)), Dianwen Ju(Fudan University)
Clinical and Translational Medicine
February 1, 2021
Cited by 37


Related Papers